2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC2826 | |||||||||||||||||||||||
Submitter : | Dr. Lance Kreplick | Date & Time: | 02/16/2006 04:02:25 | |||||||||||||||||||||
Organization : | Dr. Lance Kreplick | |||||||||||||||||||||||
Category : | Health Professional | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Flagrant violations of the law by pharmacies compounding bio-identical hormones that endanger public health should be stopped. The FDA should not disallow pharmacies from compounding / distributing bio-identical hormones. | ||||||||||||||||||||||||